vs

Side-by-side financial comparison of Garmin (GRMN) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

Garmin is the larger business by last-quarter revenue ($2.1B vs $1.1B, roughly 1.9× PERRIGO Co plc). Garmin runs the higher net margin — 24.9% vs -127.8%, a 152.7% gap on every dollar of revenue. On growth, Garmin posted the faster year-over-year revenue change (16.6% vs -2.5%). Garmin produced more free cash flow last quarter ($429.6M vs $148.6M). Over the past eight quarters, Garmin's revenue compounded faster (24.0% CAGR vs 1.3%).

Garmin Ltd. is an American multinational technology company based in Olathe, Kansas. The company designs, develops, manufactures, markets, and distributes GPS-enabled products and other navigation, communication, sensor-based, and information products to the automotive, aviation, marine, outdoors, and sport markets.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

GRMN vs PRGO — Head-to-Head

Bigger by revenue
GRMN
GRMN
1.9× larger
GRMN
$2.1B
$1.1B
PRGO
Growing faster (revenue YoY)
GRMN
GRMN
+19.1% gap
GRMN
16.6%
-2.5%
PRGO
Higher net margin
GRMN
GRMN
152.7% more per $
GRMN
24.9%
-127.8%
PRGO
More free cash flow
GRMN
GRMN
$281.0M more FCF
GRMN
$429.6M
$148.6M
PRGO
Faster 2-yr revenue CAGR
GRMN
GRMN
Annualised
GRMN
24.0%
1.3%
PRGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRMN
GRMN
PRGO
PRGO
Revenue
$2.1B
$1.1B
Net Profit
$528.7M
$-1.4B
Gross Margin
59.2%
32.6%
Operating Margin
28.9%
-116.0%
Net Margin
24.9%
-127.8%
Revenue YoY
16.6%
-2.5%
Net Profit YoY
21.3%
-3093.9%
EPS (diluted)
$2.72
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRMN
GRMN
PRGO
PRGO
Q4 25
$2.1B
$1.1B
Q3 25
$1.8B
$1.0B
Q2 25
$1.8B
$1.1B
Q1 25
$1.5B
$1.0B
Q4 24
$1.8B
$1.1B
Q3 24
$1.6B
$1.1B
Q2 24
$1.5B
$1.1B
Q1 24
$1.4B
$1.1B
Net Profit
GRMN
GRMN
PRGO
PRGO
Q4 25
$528.7M
$-1.4B
Q3 25
$401.6M
$7.5M
Q2 25
$400.8M
$-8.4M
Q1 25
$332.8M
$-6.4M
Q4 24
$435.7M
$-44.4M
Q3 24
$399.1M
$-21.0M
Q2 24
$300.6M
$-108.4M
Q1 24
$276.0M
$2.0M
Gross Margin
GRMN
GRMN
PRGO
PRGO
Q4 25
59.2%
32.6%
Q3 25
59.1%
36.1%
Q2 25
58.8%
34.4%
Q1 25
57.6%
37.6%
Q4 24
59.3%
33.9%
Q3 24
60.0%
37.2%
Q2 24
57.3%
37.0%
Q1 24
58.1%
33.1%
Operating Margin
GRMN
GRMN
PRGO
PRGO
Q4 25
28.9%
-116.0%
Q3 25
25.8%
7.0%
Q2 25
26.0%
4.3%
Q1 25
21.7%
4.5%
Q4 24
28.3%
10.0%
Q3 24
27.6%
7.4%
Q2 24
22.7%
-2.5%
Q1 24
21.6%
-5.1%
Net Margin
GRMN
GRMN
PRGO
PRGO
Q4 25
24.9%
-127.8%
Q3 25
22.7%
0.7%
Q2 25
22.1%
-0.8%
Q1 25
21.7%
-0.6%
Q4 24
23.9%
-3.9%
Q3 24
25.2%
-1.9%
Q2 24
20.0%
-10.2%
Q1 24
20.0%
0.2%
EPS (diluted)
GRMN
GRMN
PRGO
PRGO
Q4 25
$2.72
$-10.23
Q3 25
$2.08
$0.05
Q2 25
$2.07
$-0.06
Q1 25
$1.72
$-0.05
Q4 24
$2.24
$-0.32
Q3 24
$2.07
$-0.15
Q2 24
$1.56
$-0.79
Q1 24
$1.43
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRMN
GRMN
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$2.3B
Total DebtLower is stronger
Stockholders' EquityBook value
$9.0B
$2.9B
Total Assets
$11.0B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRMN
GRMN
PRGO
PRGO
Q4 25
$2.3B
Q3 25
$2.1B
$432.1M
Q2 25
$2.1B
$454.2M
Q1 25
$2.2B
$409.9M
Q4 24
$2.1B
$558.8M
Q3 24
$2.0B
$1.5B
Q2 24
$1.9B
$542.8M
Q1 24
$1.9B
$658.5M
Stockholders' Equity
GRMN
GRMN
PRGO
PRGO
Q4 25
$9.0B
$2.9B
Q3 25
$8.5B
$4.4B
Q2 25
$8.1B
$4.5B
Q1 25
$8.2B
$4.4B
Q4 24
$7.8B
$4.3B
Q3 24
$7.5B
$4.6B
Q2 24
$7.0B
$4.5B
Q1 24
$7.2B
$4.7B
Total Assets
GRMN
GRMN
PRGO
PRGO
Q4 25
$11.0B
$8.5B
Q3 25
$10.5B
$10.1B
Q2 25
$10.3B
$10.1B
Q1 25
$9.8B
$9.8B
Q4 24
$9.6B
$9.6B
Q3 24
$9.3B
$11.2B
Q2 24
$8.9B
$10.4B
Q1 24
$8.6B
$10.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRMN
GRMN
PRGO
PRGO
Operating Cash FlowLast quarter
$553.8M
$175.4M
Free Cash FlowOCF − Capex
$429.6M
$148.6M
FCF MarginFCF / Revenue
20.2%
13.4%
Capex IntensityCapex / Revenue
5.8%
2.4%
Cash ConversionOCF / Net Profit
1.05×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRMN
GRMN
PRGO
PRGO
Q4 25
$553.8M
$175.4M
Q3 25
$485.6M
$51.7M
Q2 25
$173.2M
$75.9M
Q1 25
$420.8M
$-64.5M
Q4 24
$483.9M
$312.6M
Q3 24
$258.0M
$42.2M
Q2 24
$255.3M
$9.5M
Q1 24
$435.3M
$-1.4M
Free Cash Flow
GRMN
GRMN
PRGO
PRGO
Q4 25
$429.6M
$148.6M
Q3 25
$425.1M
$29.8M
Q2 25
$127.5M
$56.7M
Q1 25
$380.7M
$-90.0M
Q4 24
$399.2M
$274.9M
Q3 24
$219.4M
$15.1M
Q2 24
$218.2M
$-18.9M
Q1 24
$402.1M
$-26.5M
FCF Margin
GRMN
GRMN
PRGO
PRGO
Q4 25
20.2%
13.4%
Q3 25
24.0%
2.9%
Q2 25
7.0%
5.4%
Q1 25
24.8%
-8.6%
Q4 24
21.9%
24.2%
Q3 24
13.8%
1.4%
Q2 24
14.5%
-1.8%
Q1 24
29.1%
-2.4%
Capex Intensity
GRMN
GRMN
PRGO
PRGO
Q4 25
5.8%
2.4%
Q3 25
3.4%
2.1%
Q2 25
2.5%
1.8%
Q1 25
2.6%
2.4%
Q4 24
4.6%
3.3%
Q3 24
2.4%
2.5%
Q2 24
2.5%
2.7%
Q1 24
2.4%
2.3%
Cash Conversion
GRMN
GRMN
PRGO
PRGO
Q4 25
1.05×
Q3 25
1.21×
6.89×
Q2 25
0.43×
Q1 25
1.26×
Q4 24
1.11×
Q3 24
0.65×
Q2 24
0.85×
Q1 24
1.58×
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRMN
GRMN

Fitness Segment$765.8M36%
Outdoor Segment$627.6M30%
Marine Segment$296.9M14%
Aviation Segment$274.2M13%
Auto Oem Segment$160.4M8%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons